{"mainPropery":{"diseaseId":5372,"diseaseName":"Troyer syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5372/troyer-syndrome","synonyms":["SPG20","Spastic paraparesis, childhood-onset, with distal muscle wasting","Spastic paraplegia, autosomal recessive, Troyer type","Autosomal recessive spastic paraplegia type 20","Spastic paraplegia 20, autosomal recessive","Cross-McKusick syndrome","Spastic paraplegia 20"],"synonyms-with-source":[{"name":"SPG20"},{"name":"Spastic paraparesis, childhood-onset, with distal muscle wasting","source":"OMIM"},{"name":"Spastic paraplegia, autosomal recessive, Troyer type","source":"OMIM"},{"name":"Autosomal recessive spastic paraplegia type 20"},{"name":"Spastic paraplegia 20, autosomal recessive","source":"OMIM"},{"name":"Cross-McKusick syndrome","source":"GHR"},{"name":"Spastic paraplegia 20","source":""}],"identifiers":[{"identifierType":"OMIM","identifierId":"275900"},{"identifierType":"ORPHANET","identifierId":"101000"},{"identifierType":"UMLS","identifierId":"C0393559"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":61,"resourceName":"Spastic Paraplegia Foundation","abbreviation":"SPF","address1":"1605 Goularte Place","address2":"","address3":"","address4":"","address5":"","city":"Fremont","state":"CA","zip":"94539-7241","country":"United States","phone":"1-877-773-4483 ","tty":"","tollFree":"","fax":"1-877-773-4483 ","email":"information@sp-foundation.org","url":"https://sp-foundation.org/","freeText":""},{"resourceID":3180,"resourceName":"Hereditary Spastic Paraplegia (HSP) Facebook Page","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"https://www.facebook.com/Hereditary-Spastic-Paraplegia-HSP-121279057942990/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/275900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=275900' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Troyer syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=troyersyndrome' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Troyer syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":346,"resourceId":1163,"resourceName":"RareConnect- Hereditary Spastic Paraplegia","descriptionText":"<a href='http://www.rareconnect.org/en/community/hereditary-spastic-paraplegia ' target='_blank'>RareConnect</a> is an online social network for patients and families to connect with one another and share their experience living with a rare disease. The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders). Click on the link above to view the community for Hereditary spastic paraplegia.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0393559' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/hereditary-spastic-paraplegia/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/troyer_syndrome/troyer_syndrome.htm' target='_blank'>National Institute of Neurological Disorders and Stroke (NINDS)</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/306713-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=101000' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=spg20' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:275900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":9796,"questionText":"What is Troyer syndrome?","answerText":"<strong>Troyer syndrome</strong> is a neurological disorder and one of the many types of <a href=\"http://www.ninds.nih.gov/disorders/hereditary_spastic_paraplegia/hereditary_spastic_paraplegia.htm\" target=\"_blank\">hereditary spastic paraplegia</a>.[10177][10175] Signs and symptoms typically begin in early childhood and may include progressive muscle weakness and stiffness (spasticity) in the legs; muscle wasting in the hands and feet; <a href=\"https://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paraplegia</a>; leg contractures; developmental delays; speech difficulty; mood swings; and short stature.[10175][10176][10177] Symptoms worsen over time, with most people needing a wheelchair by their 50s or 60s.[10177][10175] Life expectancy is normal.[10176] Troyer syndrome is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"http://ghr.nlm.nih.gov/gene/SPG20\" target=\"_blank\">SPG20</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[10175][10176] Treatment is symptomatic and supportive.[10177]","dateModified":"2015-12-08T10:55:00"},"basicQuestions":[{"questionId":9797,"questionText":"What are the signs and symptoms of Troyer syndrome?","answerText":"The signs and symptoms of Troyer syndrome can vary, and some people are more severely affected than others.[10177] Symptoms typically begin in early childhood. Most affected children have delays in walking and talking, followed by slow deterioration in both manner of walking (gait) and speech.[10176] Affected people have progressive muscle weakness and stiffness (spasticity) in the legs; muscle wasting in the hands and feet; <a href=\"https://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paraplegia</a>; leg contractures;  learning disorders; and short stature.[10175][10176][10177] Mood swings and mood disorders, causing inappropriate euphoria and/or crying, are common.[10176]<br />\r\n<br />\r\nOther features can include drooling; exaggerated reflexes (hyperreflexia) in the legs; uncontrollable movements of the arms and legs (choreoathetosis); skeletal abnormalities; and a bending outward (valgus) of the knees.[10175][10177]<br />\r\n<br />\r\nThere is generally a slow, progressive decline in muscle and nerve function, and symptoms worsen over time. Most people need a wheelchair by their 50s or 60s.[10177][10175] Affected people typically have a normal life expectancy.[10176]","dateModified":"2015-12-08T11:17:00","resourceClassificationName":"Symptoms","references":[{"referenceId":10175,"authors":"","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January, 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/troyer-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10177,"authors":"","articleTitle":"Troyer Syndrome Information Page","bookWebsiteJournalTitle":"NINDS","date":"January 3, 2012","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/troyer_syndrome/troyer_syndrome.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9798,"questionText":"What causes Troyer syndrome?","answerText":"Troyer syndrome is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"http://ghr.nlm.nih.gov/gene/SPG20\" target=\"_blank\">SPG20</a></em> gene.[10175][10176] This gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> called spartin, which is present in many body tissues, including those of the nervous system. However, the function of this protein is not fully understood. It is thought to play various roles needed for the functions of cells.[10175][10176] Troyer syndrome is assumed to be caused by a loss of function of the spartin protein. More research on the normal functions of the spartin protein is needed to better understand exactly how mutations in the <em>SPG20</em> gene cause the features of Troyer syndrome.[10176]","dateModified":"2015-12-08T11:39:00","resourceClassificationName":"Cause","references":[{"referenceId":10175,"authors":"","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January, 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/troyer-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9800,"questionText":"How is Troyer syndrome inherited?","answerText":"Troyer syndrome is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[10175][10176] This means that to be affected, a person must have a <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> in both copies of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a <a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has:\r\n<ul>\r\n    <li>\r\n    a 25% (1 in 4) chance to be affected</li>\r\n    <li>a 50% (1 in 2) chance to be an unaffected carrier like each parent</li>\r\n    <li>a 25% chance to be unaffected <em>and</em> not be a carrier.</li>\r\n</ul>","dateModified":"2015-12-08T11:40:00","resourceClassificationName":"Inheritance","references":[{"referenceId":10175,"authors":"","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January, 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/troyer-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9799,"questionText":"How might Troyer syndrome be treated?","answerText":"There are currently no treatments known to prevent or slow the progression of Troyer syndrome.[10177] Treatment aims to relieve symptoms of the disease and improve quality of life. <br />\r\n<br />\r\nTreatment for spasticity involves both exercise and medication, especially <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682530.html\" target=\"_blank\">baclofen</a> (Lioresal&reg;), which is used either orally or by intrathecal pump. <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601121.html\" target=\"_blank\">Tizanidine</a>, <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682576.html\" target=\"_blank\">dantrolene</a> (with precautions), and Botox&reg; have also been useful in reducing muscle spasticity. Daily <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007448.htm\" target=\"_blank\">physical therapy</a> is recommended.[10176]<br />\r\n<br />\r\nTreatment may also include:\r\n<ul>\r\n    <li>Occupational therapy, assistive walking devices, and ankle-foot orthotics as needed</li>\r\n    <li><a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682141.html\" target=\"_blank\">Oxybutynin</a> to reduce urinary urgency</li>\r\n    <li>Antidepressants or mood stabilizers to manage emotional or mood disorders[10176]</li>\r\n</ul>\r\n<p><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK1382/#spg20.Management\" target=\"_blank\">Additional information about the management of Troyer syndrome can be viewed on the GeneReviews Web site</a>.</p>","dateModified":"2015-12-08T11:39:00","resourceClassificationName":"Treatment","references":[{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10177,"authors":"","articleTitle":"Troyer Syndrome Information Page","bookWebsiteJournalTitle":"NINDS","date":"January 3, 2012","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/troyer_syndrome/troyer_syndrome.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9801,"questionText":"What is the long-term outlook for people with Troyer syndrome?","answerText":"Troyer syndrome is progressive, causing a gradual decline of muscle and nerve function.[10175] Affected people become more impaired as they age.[10175] However, long-term outlook (prognosis) can vary because some have a mild form of the disease while others lose the ability to walk normally.[10177] Most people with Troyer syndrome need a wheelchair by the time they are in their 50s or 60s.[10175][10176] The disease typically does not affect life expectancy.[10177]","dateModified":"2015-12-08T11:40:00","resourceClassificationName":"Prognosis","references":[{"referenceId":10175,"authors":"","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January, 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/troyer-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10177,"authors":"","articleTitle":"Troyer Syndrome Information Page","bookWebsiteJournalTitle":"NINDS","date":"January 3, 2012","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/troyer_syndrome/troyer_syndrome.htm","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12748,"relatedDiseaseName":"Hereditary spastic paraplegia - autosomal recessive inheritance","relation":"Parent","isRare":true,"hasGardPage":false}],"gardCases":[{"caseId":54204,"abbreviatedInquiry":"Our son was diagnosed with Troyer syndrome.\r\nBecause it is such a rare disease it is very difficult to find any information about the disease. And surely any information which is understandable for non experts. Can you help us to get more info about this disease?","caseQuestions":[{"questionId":9796,"questionText":"What is Troyer syndrome?","answerText":"<strong>Troyer syndrome</strong> is a neurological disorder and one of the many types of <a href=\"http://www.ninds.nih.gov/disorders/hereditary_spastic_paraplegia/hereditary_spastic_paraplegia.htm\" target=\"_blank\">hereditary spastic paraplegia</a>.[10177][10175] Signs and symptoms typically begin in early childhood and may include progressive muscle weakness and stiffness (spasticity) in the legs; muscle wasting in the hands and feet; <a href=\"https://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paraplegia</a>; leg contractures; developmental delays; speech difficulty; mood swings; and short stature.[10175][10176][10177] Symptoms worsen over time, with most people needing a wheelchair by their 50s or 60s.[10177][10175] Life expectancy is normal.[10176] Troyer syndrome is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"http://ghr.nlm.nih.gov/gene/SPG20\" target=\"_blank\">SPG20</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[10175][10176] Treatment is symptomatic and supportive.[10177]","dateModified":"2015-12-08T10:55:00","references":[{"referenceId":10175,"authors":"","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January, 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/troyer-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10177,"authors":"","articleTitle":"Troyer Syndrome Information Page","bookWebsiteJournalTitle":"NINDS","date":"January 3, 2012","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/troyer_syndrome/troyer_syndrome.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9797,"questionText":"What are the signs and symptoms of Troyer syndrome?","answerText":"The signs and symptoms of Troyer syndrome can vary, and some people are more severely affected than others.[10177] Symptoms typically begin in early childhood. Most affected children have delays in walking and talking, followed by slow deterioration in both manner of walking (gait) and speech.[10176] Affected people have progressive muscle weakness and stiffness (spasticity) in the legs; muscle wasting in the hands and feet; <a href=\"https://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paraplegia</a>; leg contractures;  learning disorders; and short stature.[10175][10176][10177] Mood swings and mood disorders, causing inappropriate euphoria and/or crying, are common.[10176]<br />\r\n<br />\r\nOther features can include drooling; exaggerated reflexes (hyperreflexia) in the legs; uncontrollable movements of the arms and legs (choreoathetosis); skeletal abnormalities; and a bending outward (valgus) of the knees.[10175][10177]<br />\r\n<br />\r\nThere is generally a slow, progressive decline in muscle and nerve function, and symptoms worsen over time. Most people need a wheelchair by their 50s or 60s.[10177][10175] Affected people typically have a normal life expectancy.[10176]","dateModified":"2015-12-08T11:17:00","resourceClassificationName":"Symptoms","references":[{"referenceId":10175,"authors":"","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January, 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/troyer-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10177,"authors":"","articleTitle":"Troyer Syndrome Information Page","bookWebsiteJournalTitle":"NINDS","date":"January 3, 2012","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/troyer_syndrome/troyer_syndrome.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9798,"questionText":"What causes Troyer syndrome?","answerText":"Troyer syndrome is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"http://ghr.nlm.nih.gov/gene/SPG20\" target=\"_blank\">SPG20</a></em> gene.[10175][10176] This gene gives the body instructions to make a <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> called spartin, which is present in many body tissues, including those of the nervous system. However, the function of this protein is not fully understood. It is thought to play various roles needed for the functions of cells.[10175][10176] Troyer syndrome is assumed to be caused by a loss of function of the spartin protein. More research on the normal functions of the spartin protein is needed to better understand exactly how mutations in the <em>SPG20</em> gene cause the features of Troyer syndrome.[10176]","dateModified":"2015-12-08T11:39:00","resourceClassificationName":"Cause","references":[{"referenceId":10175,"authors":"","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January, 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/troyer-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9800,"questionText":"How is Troyer syndrome inherited?","answerText":"Troyer syndrome is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[10175][10176] This means that to be affected, a person must have a <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> in both copies of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a <a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has:\r\n<ul>\r\n    <li>\r\n    a 25% (1 in 4) chance to be affected</li>\r\n    <li>a 50% (1 in 2) chance to be an unaffected carrier like each parent</li>\r\n    <li>a 25% chance to be unaffected <em>and</em> not be a carrier.</li>\r\n</ul>","dateModified":"2015-12-08T11:40:00","resourceClassificationName":"Inheritance","references":[{"referenceId":10175,"authors":"","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January, 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/troyer-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9799,"questionText":"How might Troyer syndrome be treated?","answerText":"There are currently no treatments known to prevent or slow the progression of Troyer syndrome.[10177] Treatment aims to relieve symptoms of the disease and improve quality of life. <br />\r\n<br />\r\nTreatment for spasticity involves both exercise and medication, especially <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682530.html\" target=\"_blank\">baclofen</a> (Lioresal&reg;), which is used either orally or by intrathecal pump. <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601121.html\" target=\"_blank\">Tizanidine</a>, <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682576.html\" target=\"_blank\">dantrolene</a> (with precautions), and Botox&reg; have also been useful in reducing muscle spasticity. Daily <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007448.htm\" target=\"_blank\">physical therapy</a> is recommended.[10176]<br />\r\n<br />\r\nTreatment may also include:\r\n<ul>\r\n    <li>Occupational therapy, assistive walking devices, and ankle-foot orthotics as needed</li>\r\n    <li><a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682141.html\" target=\"_blank\">Oxybutynin</a> to reduce urinary urgency</li>\r\n    <li>Antidepressants or mood stabilizers to manage emotional or mood disorders[10176]</li>\r\n</ul>\r\n<p><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK1382/#spg20.Management\" target=\"_blank\">Additional information about the management of Troyer syndrome can be viewed on the GeneReviews Web site</a>.</p>","dateModified":"2015-12-08T11:39:00","resourceClassificationName":"Treatment","references":[{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10177,"authors":"","articleTitle":"Troyer Syndrome Information Page","bookWebsiteJournalTitle":"NINDS","date":"January 3, 2012","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/troyer_syndrome/troyer_syndrome.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9801,"questionText":"What is the long-term outlook for people with Troyer syndrome?","answerText":"Troyer syndrome is progressive, causing a gradual decline of muscle and nerve function.[10175] Affected people become more impaired as they age.[10175] However, long-term outlook (prognosis) can vary because some have a mild form of the disease while others lose the ability to walk normally.[10177] Most people with Troyer syndrome need a wheelchair by the time they are in their 50s or 60s.[10175][10176] The disease typically does not affect life expectancy.[10177]","dateModified":"2015-12-08T11:40:00","resourceClassificationName":"Prognosis","references":[{"referenceId":10175,"authors":"","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January, 2008","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/troyer-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10176,"authors":"Patel H, Harlalka G & Crosby A","articleTitle":"Troyer syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"August 4, 2011","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1382/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10177,"authors":"","articleTitle":"Troyer Syndrome Information Page","bookWebsiteJournalTitle":"NINDS","date":"January 3, 2012","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/troyer_syndrome/troyer_syndrome.htm","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9413,"phenoTypeName":"Abnormal cerebellum morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3159,"phenoTypeName":"Abnormal hand morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13598,"phenoTypeName":"Babinski sign","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13409,"phenoTypeName":"Constipation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14142,"phenoTypeName":"Delayed speech and language development","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11698,"phenoTypeName":"Dysuria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10388,"phenoTypeName":"Hypertelorism","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14292,"phenoTypeName":"Impaired vibratory sensation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5679,"phenoTypeName":"Joint hypermobility","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8729,"phenoTypeName":"Motor delay","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11162,"phenoTypeName":"Overbite","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5658,"phenoTypeName":"Slurred speech","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5224,"phenoTypeName":"Spastic dysarthria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11407,"phenoTypeName":"Spastic paraparesis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9417,"phenoTypeName":"Specific learning disability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13597,"phenoTypeName":"Upper limb muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3067,"phenoTypeName":"Abnormal thumb morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6101,"phenoTypeName":"Abnormality of the nares","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4289,"phenoTypeName":"Ankle clonus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14132,"phenoTypeName":"Anxiety","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1208,"phenoTypeName":"Clinodactyly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5271,"phenoTypeName":"Distal amyotrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5603,"phenoTypeName":"Downslanted palpebral fissures","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6009,"phenoTypeName":"Emotional lability","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9886,"phenoTypeName":"Epicanthus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7947,"phenoTypeName":"Genu valgum","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14131,"phenoTypeName":"Hallucinations","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4766,"phenoTypeName":"Hoarse voice","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11305,"phenoTypeName":"Low-set ears","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9844,"phenoTypeName":"Microcephaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5841,"phenoTypeName":"Occasional neurofibromas","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11247,"phenoTypeName":"Panic attack","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3896,"phenoTypeName":"Pes cavus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10382,"phenoTypeName":"Prominent nose","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6006,"phenoTypeName":"Psychosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11439,"phenoTypeName":"Sleep disturbance","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13452,"phenoTypeName":"Spastic gait","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":305,"phenoTypeName":"Speech apraxia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5835,"phenoTypeName":"Bilateral vestibular Schwannoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10286,"phenoTypeName":"Cafe-au-lait spot","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11461,"phenoTypeName":"Cortical cataract","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4299,"phenoTypeName":"Ependymoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10060,"phenoTypeName":"Hydronephrosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8471,"phenoTypeName":"Juvenile posterior subcapsular lenticular opacities","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":7948,"phenoTypeName":"Meningioma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5840,"phenoTypeName":"Retinal hamartoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10434,"phenoTypeName":"Tinnitus","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5836,"phenoTypeName":"Unilateral vestibular Schwannoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11411,"phenoTypeName":"Vertigo","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5838,"phenoTypeName":"Astrocytoma","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":3056,"phenoTypeName":"Brachydactyly","percentRanges":"-"},{"phenoTypeId":13913,"phenoTypeName":"Camptodactyly","percentRanges":"-"},{"phenoTypeId":8731,"phenoTypeName":"Cerebellar atrophy","percentRanges":"-"},{"phenoTypeId":15655,"phenoTypeName":"Childhood onset","percentRanges":"-"},{"phenoTypeId":11432,"phenoTypeName":"Difficulty walking","percentRanges":"-"},{"phenoTypeId":11398,"phenoTypeName":"Drooling","percentRanges":"-"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","percentRanges":"-"},{"phenoTypeId":9396,"phenoTypeName":"Dysmetria","percentRanges":"-"},{"phenoTypeId":11456,"phenoTypeName":"Epiretinal membrane","percentRanges":"-"},{"phenoTypeId":5672,"phenoTypeName":"Flexion contracture","percentRanges":"-"},{"phenoTypeId":3897,"phenoTypeName":"Hammertoe","percentRanges":"-"},{"phenoTypeId":11409,"phenoTypeName":"Headache","percentRanges":"-"},{"phenoTypeId":15072,"phenoTypeName":"Hyperextensible hand joints","percentRanges":"-"},{"phenoTypeId":13909,"phenoTypeName":"Hyperplasia of midface","percentRanges":"-"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","percentRanges":"-"},{"phenoTypeId":8722,"phenoTypeName":"Intellectual disability, mild","percentRanges":"-"},{"phenoTypeId":4290,"phenoTypeName":"Knee clonus","percentRanges":"-"},{"phenoTypeId":10590,"phenoTypeName":"Kyphoscoliosis","percentRanges":"-"},{"phenoTypeId":13670,"phenoTypeName":"Lower limb muscle weakness","percentRanges":"-"},{"phenoTypeId":2230,"phenoTypeName":"Peripheral neuropathy","percentRanges":"-"},{"phenoTypeId":5839,"phenoTypeName":"Peripheral Schwannoma","percentRanges":"-"},{"phenoTypeId":3903,"phenoTypeName":"Short foot","percentRanges":"-"},{"phenoTypeId":8712,"phenoTypeName":"Spastic paraplegia","percentRanges":"-"},{"phenoTypeId":4472,"phenoTypeName":"Upper limb spasticity","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Troyer_syndrome"}